The warnings around products that have not been evaluated by the TGA echo GPs concerns about the rise in import, supply, compounding and advertising of such products and the potential associated safety risks
Introduction Once considered a niche therapeutic area, obesity treatment has now become a strategic frontier for innovation, investment, and healthcare reform
Tirzepatide is currently being investigated in the SURMOUNT cardiovascular outcomes trial of adults with obesity
They discuss how these drugs work, why muscle mass, not just body weight, is the true marker of health, and why many people who lose weight too quickly end up weaker, not healthier
Iron metabolism and the polycystic ovary syndrome